CELH
Celsius Holdings, Inc.
CELH has the edge over EPC overall, supported by stronger fundamentals and stronger valuation.
EPC
Edgewell Personal Care Company
EPC trails on the overall score without a compensating advantage in the available component scores.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
EPC Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Healthy | |
| Weak |
EPC's cash flow is currently healthy, but its revenue, profitability and balance sheet are under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
EPC PE Valuation
EPC has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
EPC Forward outlook
There aren't enough analyst estimates for EPC to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
EPC Earnings Per Share
EPC and CELH do not have enough comparable growth data to identify a winner.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over EPC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over EPC on profitability, with a higher operating margin.
EPC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $570.1M | -9.1% |
| Q1 2026 | $519.5M | -11% |
| Q4 2025 | $422.8M | -12% |
| Q3 2025 | $537.2M | +3.8% |
| Q2 2025 | $627.2M | -3.2% |
| Q1 2025 | $580.7M | -3.1% |
| Q4 2024 | $478.4M | -2.1% |
| Q3 2024 | $517.6M | -3.1% |
EPC's revenue is shrinking: $570M last quarter, down 9.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 4.4% | -4.2 points |
| Q1 2026 | 3.5% | -6.6 points |
| Q4 2025 | -4.5% | -8.7 points |
| Q3 2025 | -6.8% | -11 points |
| Q2 2025 | 8.6% | -4.2 points |
| Q1 2025 | 10% | -1.6 points |
| Q4 2024 | 4.2% | -1.1 points |
| Q3 2024 | 3.9% | -6.2 points |
EPC's operating margin was 4.4% last quarter, down 4.2 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
EPC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $103.1M | +3.8% |
| Q1 2026 | $40.3M | +44% |
| Q4 2025 | -$137.5M | -$5.1M |
| Q3 2025 | $46.5M | -2.7% |
| Q2 2025 | $99.3M | +12% |
| Q1 2025 | $28M | -76% |
| Q4 2024 | -$132.4M | -$53M |
| Q3 2024 | $47.8M | +63% |
EPC still generates free cash flow, though less than at its 2021 peak: $52M over the past year.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over EPC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
EPC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -200K shares |
| 1 year | -0.9% | -400K shares |
| 3 years | -10% | -5.2M shares |
| 5 years | -16% | -8.8M shares |
| Available history | -14% | -7.5M shares |
EPC has 47M diluted shares, down 0.9% from a year ago, with $16M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | $15.8M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $24.5M |
| Q1 2025 | $35.4M |
| Q4 2024 | $30.3M |
| Q3 2024 | $18.3M |
EPC spent $16M buying back its own shares over the past year, down 85% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over EPC on leverage, with a lower net debt burden relative to earnings.
EPC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 12.0x | High |
| Q1 2026 | 9.2x | High |
| Q4 2025 | 8.9x | High |
| Q3 2025 | 6.2x | High |
| Q2 2025 | 4.9x | High |
| Q1 2025 | 4.7x | High |
| Q4 2024 | 4.5x | High |
| Q3 2024 | 3.7x | Elevated |
EPC's net debt is about 12 years of its operating earnings (EBITDA), up from 4.9 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
EPC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.1 | Neutral |
| Stochastic | 58.8 | Neutral |
EPC's weekly RSI is 60 (neutral) and its Stochastic is 59 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
EPC PE vs Consumer Defensive Sector
| Metric | EPC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
EPC has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
EPC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $28.0 | 2.7% above |
| 20 week MA | $28.0 | 2.8% above |
| 50 week MA | $23.4 | 23% above |
| 100 week MA | $24.9 | 16% above |
| 200 week MA | $31.8 | 9.5% below |
EPC has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
EPC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.9 | $35.6 | +15% |
| 2021 | $35.6 | $44.6 | +25% |
| 2022 | $44.6 | $39.1 | -12% |
| 2023 | $39.1 | $36.6 | -6.4% |
| 2024 | $36.6 | $34.1 | -6.9% |
| 2025 | $34.1 | $17.5 | -49% |
| 2026 YTD | $17.5 | $28.7 | +64% |
EPC has the edge over CELH on returns for 2026, with the stronger performance.